# Atorvastatin in Relapsing-Remitting Multiple Sclerosis

> **NCT00616187** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 41 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** interferon beta treatment to add-on atorvastatin treatment
- **DRUG:** untreated to atorvastatin treatment

## Key facts

- **NCT ID:** NCT00616187
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2007-06
- **Final completion:** —
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00616187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00616187, "Atorvastatin in Relapsing-Remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00616187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*